| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |